Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute


Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.

You May Also Like

Bullard says February job report increases chance of Fed cutting interest rates sooner

A former top Federal Reserve official said Friday that the U.S. February…

The stock market could stop short of new highs — but that seems unlikely now

Buy signals and bullish indicators are coming into focus.

Biden rushes $4.28 billion in student-debt relief before White House exit

Tens of thousands of public servants will have $4.28 billion in student…

This Tesla and Alphabet earnings play could profit from stock-market volatility

Both of these stocks often see big postearnings moves. Meanwhile, the broader…